Clinical trial · Observational
Perfusion Scanning's for Kidney Tumors
NCT01971905CI-TRIAL-00031350completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the ability of perfusion CT/US-scanning to facilitate recognition of different tumour sub-types in small renal masses less than 7 cm by non-invasive imagining technology.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Kidney Cancer | Malignant Kidney Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Oben label
- description
- There is no intervention on this descriptive study
Primary outcomes (1)
- measure
- To recognize different subtype's renal tumor by non invasive scanning.
- timeFrame
- one year
- description
- A perfusion scanning will be performed prior to nephrectomy and the curve of contrast perfusion to the tumor and normal kidney will be compared according to histological finding
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients suspecting to have renal tumors by CT/UL-scanning. 2. Patients age between 35 and 75 years 3. Normal renal function 4. Can read and understand Danish 5. Non - metastasis disease detected by scanning Exclusion Criteria: 1. Patients have a nephropathy (defined as e-GFR less than 50 ml/min/1.73cm³). 2. Previous allergic reaction to intravenous contrast material. 3. Untreated hyperthyroidism. 4. Pregnancy.
References
Publications (0)
Data not yet available
No reference posted for this study.